Treating West Nile Virus with High Quality St. Johns Wort

West Nile Virus, although new to the U.S., is well-documented. The Centers for Disease Control identifies it as a flavivirus, a member of the Togavirus family. It is closely related to yellow fever and dengue fever. This is important because the Togavirus family are encapsulated viruses, i.e., they are covered with a lipid (fatty) coating.

This is exciting, because it means the virus is accessible to treatment utilizing high quality St. John's Wort (SJW). Several studies have been done on a variety of encapsulated viruses, including herpes simplex virus types 1 and 2, parainfluenza virus, vaccinia virus, cytomegalovirus and several retroviruses including HIV1, 2, 3, 4, 8, 9, 10.

Non-encapsulated viruses or "naked" viruses were also studied for comparison purposes10,13.

SJW was a potent anti-viral agent across a variety of encapsulated virus families, but showed no activity against naked viruses.

Unlike a vaccine that is specific to each organism, SJW is active against encapsulated viruses by a variety of mechanisms, including light activation, interference with DNA transcription, impairing the assembly of intact viral particles and the lipophilic (fat-loving) nature of the ring structures (the quinone and phenolic groups)4, 6, 7, 9, 11, 12, 13, 14, 15. These ring structures are critical to the biologic activity of SJW.

From these results, it is reasonable to use high quality, pharmaceutical grade SJW in combating West Nile Virus, since there are no effective pharmaceutical agents.

Quality is critical since the level of hypericin and pseudohypericin are key. I can only recommend the SJW product produced by Medi-Herb, which is a pharmaceutical house in Australia, adhering to pharmaceutical manufacturing standards. The product is distributed by Standard Process through alternative health care practitioners, including doctors of chiropractic, acupuncturists and veterinarians. SJW is quite unstable and the active ingredients degrade on store shelves. An independent analysis of 3 products (all of which were certified to contain 0.3% hypericin) were shown to be widely variant, with one product 25% below label claims. It is critically important that the phytochemical integrity of the whole plant be preserved for maximum efficacy.16

References: 1Andersen DO, Weber ND, Wood SG et al. Antiviral Res 1991; 16(2): 185-196. 2Lopez-Bazzocchi I, Hudson JB, Towers GHN. Photochem.Photopbiol. 1991; 54(1): 95-98. 3Moraleda G, Wu TT, Jilbert AR et al. Antiviral Res 1993; 20: 235-247. 4Tang J, Colacino JM, Larsen SH et al. Antiviral Res 1990; 13 (6): 313-325. 5Hudson JB, Harris L, Towers GHN. Antiviral Res 1993; 20 (2):173-178. 6Lenard J, Rabson A, Vanderoef R. Proc Natl Acad Sci USA 1993; 90 (1): 158-162. 7Degar S, Prince AM, Pascual D et al. AIDS Res Hum Retroviruses 1992; 8 (11): 1929-1936. 8Carpenter S, Kraus GA. Photochem Photobiol 1991; 53 (2): 169-174. 9Lavie G, Valentine F, Levin B et al. Proc Natl Acad Sci USA 1989; 86 (15): 5963-5967. 10Meruelo D, Lavie G, Lavie D et al. Proc Natl Acad Sci USA 1988; 85 (14): 5230-5234. 11Kraus GA, Pratt D, Tossberg J et al. Biochem Biophys Res Commun 1990; 172 (1): 149-153. 12Takahashi I, Nakanishi S, Kobayashi E et al. Biochem Biophys Res Commun 1989; 165 (3): 1207-1212. 13De Witte P, Agostinis P, Van Lint J et al. Biochem Pharmacol 1993; 46 (11): 1929-1936. 14Panossian AG, Gabrielian E, Manvelian V et al. Phytomed 1996; 3 (1): 19-28. 15Lavie G, Mazur Y, Lavie D et al. Transfusion 1995; 35 (5): 392-400. 16Constantine GH, Karchesy J. Variations in Hypericin concentrations in Hypericum perforatum L. and commercial products. Pharmaceutical Biology 1998; 36 (5): 365-367.

Dr. N. Rowan Richards was recently awarded the distinction of being one of the top five chiropractors in the state of California. She is a Diplomate of the American Board of Chiropractic Internists, a certified herbalist, and a Fellow of the International Academy of Clinical Acupuncture. Dr. Richards has been in practice for over seventeen years providing caring, individualized complete alternative health care in the Los Angeles area. Her web site is www.richardsfamilyhealth.com

A recent laboratory study has shed new light on the possibility of a nexus between carbon nanotube exposure and the asbestos-like health effects. Carbon nanotubes are molecular-level structures that are now being used in thousands of products from tennis rackets and hair dryers to computer chips and electronics. They are renowned for their unparalleled strength and remarkably low mass, and were seen by a number of as the next frontier of product durability........

The Minnesota Department of Health is launching two major studies to answer long-simmering questions about taconite and human health. The agency says men in northeastern Minnesota have twice the expected rate of a rare form of cancer called mesothelioma. It's caused by asbestos, but the Health Department wants to find out whether it can also be caused by fibers in the taconite on the Iron Range........

A deal is near on legislation banning the use of asbestos, a fibrous mineral often used in brake linings, gaskets, cement products and even yarns and threads imported into the country despite its deadly health risks. Sen. Patty Murray, D-Wash., a leading advocate of the ban, and Sen. Johnny Isakson, R-Ga., said Tuesday that they are within a week or two of wrapping up a compromise that also would authorize $50 million in research to combat the health effects that have killed as a number of as 231,000 people since 1980 and could claim at least that a number of more by 2040........

What would be more inspiring for mesothelioma patients than listening to the longest mesothelioma survivor in the world? Do you know Paul Kraus? He is the inspiration behind a number of patients with the diagnosis of one of the deadliest forms of cancer called mesothelioma. I have been personally moved by his story........

There is exciting news for patients with mesothelioma in the making. Two pharmaceutical companies have started a clinical phase II clinical trial to test the efficacy and activity of a new drug in mesothelioma. This new drug is named as PXD101. This is a small molecule histone deacetylase inhibitor........